NCT03878381View on ClinicalTrials.gov

Investigating the Wrinkle Reduction Potential of a Novel Compounded Skin Care Cream

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

October 29, 2022

Study Completion Date

October 29, 2022

Conditions
Skin Care
Interventions
COMBINATION_PRODUCT

Skin Care Cream

The skin care regimen we will be testing includes ingredients such Hyaluronic acid 1%, Vitamin E Acetate, Vitamin A Acetate, Co-enzyme Q 10, L-Arginine, L-glutamine, Phytonadione, Argireline Peptide solution, GABA, Vitamin C, glycolic acid, and Fenugreek.

DRUG

Placebo

The placebo will be a formula with no active ingredients

Trial Locations (1)

48124

WSUPG Dermatology, Dearborn

All Listed Sponsors
lead

Wayne State University

OTHER

NCT03878381 - Investigating the Wrinkle Reduction Potential of a Novel Compounded Skin Care Cream | Biotech Hunter | Biotech Hunter